Epigenetic approaches in the treatment of myelodysplastic syndromes: clinical utility of azacitidine
Steven E McCormack, Erica D WarlickDepartment of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota, USAAbstract: Myelodysplastic syndromes (MDS) are a varied group of diseases leading to ­significant morbidity and mortality....
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2010-07-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | http://www.dovepress.com/epigenetic-approaches-in-the-treatment-of-myelodysplastic-syndromes-cl-a4893 |